Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications
Manon Galoppin, Saniya Kari, Sasha Soldati, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Effects of Dietary Modification Based on Complementary and Alternative Iranian Medicine in Patients with Secondary-Progressive Multiple Sclerosis: A Randomized Controlled Clinical Trial
Amir Reza Moravejolahkami, Saeid Hadi, Vahid Hadi, et al.
Journal of Integrative and Complementary Medicine (2023) Vol. 29, Iss. 11, pp. 747-756
Closed Access | Times Cited: 3
Multiple sclerosis is associated with adverse outcomes following hip and knee arthroplasty: A systematic review and meta-analysis of observational studies
Tao Cheng, Xin Mao, Liang Hao
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104956-104956
Closed Access | Times Cited: 2
Co-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies
Enoch Kim, Marla C. Fortoul, Derek Weimer, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 105027-105027
Closed Access | Times Cited: 2
Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder
Natalie K. Boyd, Julia Nguyen, Mellad Khoshnood, et al.
Journal of Neurodevelopmental Disorders (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis
Maria Rodi, Anne-Lise de Lastic, Ioannis Panagoulias, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6092-6092
Open Access
OS BENEFÍCIOS DE SUPLEMENTAÇÃO COM VITAMINA D PARA A MELHORA DA QUALIDADE DE VIDA DE PACIENTES COM ESCLEROSE MÚLTIPLA
Fernanda Toledo dos Santos, Gracielly Fernandes Nunes, Kamila Noleto Bastos, et al.
Revista Contemporânea (2024) Vol. 4, Iss. 8, pp. e5335-e5335
Open Access
The Potential Preventive and Therapeutic Role of Vitamin D in MS
Rayyah R. Alkhanjari, Maitha M. Alhajeri, Nadia Rabeh, et al.
(2024), pp. 107-123
Closed Access
The role of vitamin D in multiple sclerosis and its mechanisms of action
Agata Kowalczyk, Justyna Kiełbasa, Magda Przestrzelska, et al.
Quality in Sport (2024) Vol. 19, pp. 54188-54188
Open Access
White Matter Lesion Volumes on 3‐T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years
Mariaan Jaftha, Frances Robertson, Susan J. van Rensburg, et al.
Multiple Sclerosis International (2024) Vol. 2024, Iss. 1
Open Access
Vitamin D affects antiphospholipid syndrome by regulating T cells (Review)
Rongxiu Huo, Yanting Yang, Chengcheng Wei, et al.
International Journal of Molecular Medicine (2024) Vol. 55, Iss. 2
Closed Access
Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing–Remitting Multiple Sclerosis
Martyna Lis, Natalia Niedziela, Jowita Adamczyk-Zostawa, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14119-14131
Open Access
Multiple sclerosis with comorbidity depression and its association with vitamin D deficiency in a narrative review of the current literature
Hans-Klaus Goischke
Exploration of neuroscience (2023), pp. 160-192
Open Access | Times Cited: 1
CITE-seq reveals inhibition of NF-κB pathway in B cells from vitamin D-treated multiple sclerosis patients
Manon Galoppin, Manon Rival, Anaïs Louis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
Brian Reed, Sayan Dutta
Drugs and Drug Candidates (2023) Vol. 2, Iss. 4, pp. 883-897
Open Access | Times Cited: 1
1,25(OH)2D3 Differently Modulates the Secretory Activity of IFN-DC and IL4-DC: A Study in Cells from Healthy Donors and MS Patients
Isabella Sanseverino, Arturo Rinaldi, Cristina Purificato, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6717-6717
Open Access
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling
Maud Bagnoud, Jana Remlinger, Marine Massy, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2291-2291
Open Access
Multiple Sclerosis: New Insights into Molecular Pathogenesis and Novel Platforms for Disease Treatment
Majid Dejbakht, Morteza Akhzari, Sajad Jalili, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 2, pp. 175-197
Closed Access
The Role of Vitamin D in Multiple Sclerosis
Kübra Küçükyilmaz
Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi (2023) Vol. 7, Iss. 3, pp. 742-755
Open Access
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Eleftheria Kodosaki, William J. Watkins, Sam Loveless, et al.
Research Square (Research Square) (2023)
Open Access
Vitamin D mechanisms of protection in multiple sclerosis
Colleen E. Hayes, Anne Astier, Matthew R. Lincoln
Elsevier eBooks (2023), pp. 1129-1166
Closed Access
Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
Hans-Klaus Goischke
Medical Research Archives (2022) Vol. 10, Iss. 12
Open Access
Previous Page - Page 2

Scroll to top